telmisartan has been researched along with Endometrioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, Y; Körbel, C; Laschke, MW; Menger, MD; Nenicu, A | 2 |
2 other study(ies) available for telmisartan and Endometrioma
| Article | Year |
|---|---|
Combination therapy with telmisartan and parecoxib induces regression of endometriotic lesions.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Caspase 3; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Drug Therapy, Combination; Endometriosis; Female; Isoxazoles; Matrix Metalloproteinase 9; Mice, Inbred C57BL; PPAR gamma; Proto-Oncogene Proteins c-akt; Telmisartan; Ultrasonography | 2017 |
Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-γ by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Disease Models, Animal; Down-Regulation; Endometriosis; Female; Gene Expression Profiling; Mice; Neovascularization, Pathologic; Peritoneal Diseases; Pioglitazone; PPAR gamma; Telmisartan; Thiazolidinediones; Up-Regulation | 2014 |